Glycine

integrin subunit alpha V ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32688289 Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy. 2020 Sep-Oct 1
2 29558951 Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide. 2018 Mar 20 1
3 27768593 Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma. 2017 Jan 3 1
4 28004516 Interaction Mechanism and Clustering among RGD Peptides and Integrins. 2017 May 2
5 28110537 Dimerization of Cell-Adhesion Molecules Can Increase Their Binding Strength. 2017 Feb 14 1
6 29053416 Imaging of Integrin αvβ3 Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer 99mTc-IDA-D-[c(RGDfK)]2. 2017 Oct 1
7 26905697 Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors. 2016 Oct 1
8 23796630 RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia. 2014 Mar 1
9 25207865 Integrin α(V)β(3)-targeted magnetic nanohybrids with enhanced antitumor efficacy, cell cycle arrest ability, and encouraging anti-cell-migration activity. 2014 Oct 8 1
10 23651498 Imaging of integrin α(V)β(3) expression using (68)Ga-RGD positron emission tomography in pediatric cerebral infarct. 2013 Jun 1
11 24206140 Development of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedside. 2013 Dec 1
12 22272823 A concise review of current radiopharmaceuticals in tumor angiogenesis imaging. 2012 1
13 22455451 Dual function of RGD-modified VEGI-192 for breast cancer treatment. 2012 Apr 18 1
14 22664242 Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers. 2012 1
15 21447361 Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. 2011 Jul 30 1
16 19882657 Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. 2010 Jan 1
17 20184307 Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature. 2010 Mar 17 1
18 19159928 (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. 2009 Jun 1
19 19225614 A photostable fluorescent probe for targeted imaging of tumour cells possessing integrin alpha(v)beta(3). 2009 Mar 1
20 19259068 Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. 2009 May 1
21 19360404 (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. 2009 Sep 1
22 19719118 Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. 2009 Dec 1
23 17983645 Mechanisms of nongenomic actions of thyroid hormone. 2008 May 1
24 17166537 Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. 2007 Feb 1
25 16418218 Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. 2006 Feb 1 1
26 17009846 Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. 2006 Sep-Oct 1
27 15898744 Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization. 2005 May-Jun 1
28 22457887 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid) 2004 1
29 22457888 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) 2004 1
30 22457890 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) 2004 1
31 11884718 Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. 2002 Apr 5 1
32 11779085 Integrins as targets of angiogenesis inhibition. 2001 Nov-Dec 1
33 10773347 High affinity interactions of Coxsackievirus A9 with integrin alphavbeta3 (CD51/61) require the CYDMKTTC sequence of beta3, but do not require the RGD sequence of the CAV-9 VP1 protein. 2000 May 2
34 10998238 Ligand-integrin alpha v beta 3 interaction determined by photoaffinity cross-linking: a challenge to the prevailing model. 2000 Sep 12 1
35 8636223 Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3. 1996 Feb 1
36 8036014 Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. 1994 Aug 2
37 1717468 Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha v beta 3 and its ligand. 1991 Oct 15 1